Introduction The novel coronavirus disease of 2019 (COVID-19) is associated with
significant morbidity and mortality. The impact of thrombotic complications has been …

The novel coronavirus (severe acute respiratory syndrome CoV-2 [SARS-CoV-2]), also
known as COVID-19, is a single-stranded enveloped RNA virus that created a Public Health …

This study aims to review the available literature pertinent to vascular complications in
COVID-19. A systematic search was performed using PubMed and Google Scholar to …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
(SARS-CoV-2) is associated with a heightened risk of thrombotic events. 1 We sought to …

Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …

Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Arterial thrombotic disease (atherosclerotic cardiovascular disease, CVD) and venous
thromboembolism (VTE)(comprising of deep vein thrombosis (DVT) and pulmonary …

Objectives: Recent studies have reported a high prevalence of thrombotic events in
coronavirus disease 2019. However, the significance of thromboembolic complications has …

Abstract Coronavirus-19 disease (COVID-19), a zoonosis, was first reported in the city of
Wuhan, province of Hubei, China in December 2019. The disease is caused by the Severe …

Purpose To analyze the survival of patients hospitalized with COVID-19 and who presented
some vascular thrombotic complication. Material and Methods All consecutive patients with …